Search company, investor...



Series A | Alive

Total Raised


Last Raised

$1.8M | 13 yrs ago

About AngioLogix

AngioLogix is a provider of cardiovascular health diagnostics.

Headquarters Location

1793 San Ramon Ave Suite 100

Mountain View, California, 94043,

United States


Missing: AngioLogix's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: AngioLogix's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

AngioLogix Patents

AngioLogix has filed 2 patents.

patents chart

Application Date

Grant Date


Related Topics




Diabetes, Cardiology, Angiology, Medical terminology, Measurement


Application Date


Grant Date



Related Topics

Diabetes, Cardiology, Angiology, Medical terminology, Measurement



AngioLogix Frequently Asked Questions (FAQ)

  • Where is AngioLogix's headquarters?

    AngioLogix's headquarters is located at 1793 San Ramon Ave, Mountain View.

  • What is AngioLogix's latest funding round?

    AngioLogix's latest funding round is Series A.

  • How much did AngioLogix raise?

    AngioLogix raised a total of $1.8M.

  • Who are the investors of AngioLogix?

    Investors of AngioLogix include Wharton Venture Initiation Program.

  • Who are AngioLogix's competitors?

    Competitors of AngioLogix include Affidea, Biodesix, Signature Diagnostics, Pathwork Diagnostics, Cylex and 11 more.

Compare AngioLogix to Competitors


ProteoGenix offers maternal-fetal diagnostics


LabNow has developed the LabNow System to conduct healthcare-related diagnostics at the point-of-care.

Hx Diagnostics

Hx Diagnostics offers rapid diagnostics for seasonal and emerging infectious diseases.

Expression Diagnostics

XDx is a molecular diagnostics company focused on the discovery, development and commercialization of non-invasive gene expression testing in the areas of transplant medicine and autoimmunity. Per the company, they have developed a proprietary method of utilizing gene expression in blood that aims to provide a new tool for physicians to manage the care of heart transplant patients. The molecular expression technology developed and implemented by XDx in heart transplant patient management is currently being explored to assist with other diseases that involve the immune system.

Ativa Medical

Ativa Medical is a medical diagnostics company that is working to make diagnostic test results available in moments, rather than hours and days.

Cleveland Biosensors

Cleveland Biosensors produces the BioFiniti Point-Of-Care diagnostics system - rapid, quantitative, portable instruments using disposable microfluidic cartridges.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.